StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report published on Friday. The firm issued a sell rating on the stock.
Separately, HC Wainwright lifted their price objective on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
View Our Latest Stock Analysis on SenesTech
SenesTech Stock Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What Are Dividend Challengers?
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.